MEDNAX, Inc. (NYSE:MD) Q1 2021 Earnings Conference Call May 7, 2021 9:00 AM ET Company Representatives Mark Ordan - Chief Executive Officer Marc Richards - Chief Financial Officer Mack Hinson - President-Pediatrix and Obstetrix Medical Group James Swift - Chief Development Officer Dominic Andreano - Executive Vice President, General Counsel and Secretary John Pepia - Senior Vice President, Chief Accounting Officer Charles Lynch - Senior Vice President, Finance and Strategy Conference Call Participants Kevin ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 Mednax, Inc. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdictio ...

MEDNAX, Inc. (NYSE:MD) Q4 2020 Earnings Conference Call February 18, 2021 9:00 AM ET Company Participants Charles Lynch ??? Senior Vice President, Finance and Strategy Mark Ordan ??? Chief Executive Officer Marc Richards ??? Chief Financial Officer Mack Hinson ??? President-Pediatrix and Obstetrix Medical Group Conference Call Participants Rob Moon ??? Credit Suisse Ralph Giacobbe ??? Citi Kevin Fischbeck ??? Bank of America Pito Chickering ??? Deutsche Bank Nick Spiekhout ??? William Blair Whit Mayo ??? UB ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction of inco ...

MEDNAX, Inc. (NYSE:MD) Q3 2020 Earnings Conference Call November 6, 2020 9:00 AM ET Company Participants Charles Lynch - VP of Strategy and IR Mark Ordan - CEO Marc Richards - EVP & CFO Roger Hinson - President, Pediatrix and Obstetrix Medical Groups Conference Call Participants A.J. Rice - Credit Suisse Brian Tanquilut - Jefferies Gary Taylor - JP Morgan Whit Mayo - UBS Kevin Fischbeck - Bank of America Nick Spiekhout - William Blair Pito Chickering - Deutsche Bank Ralph Giacobbe - Citi Operator Ladies a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdi ...

MEDNAX, Inc. (NYSE:MD) Q2 2020 Earnings Conference Call July 30, 2020 10:00 AM ET Company Participants Charles Lynch - Investor Relations Mark Ordan - Chief Executive Officer Stephen Farber - Chief Financial Officer Conference Call Participants A.J. Rice - Cr??dit Suisse Ralph Giacobbe - Citi Kevin Fischbeck - Bank of America Nick Spiekhout - William Blair Pito Chickering - Deutsche Bank Brian Tanquilut ??? Jefferies Rishi Parekh - Barclays Whit Mayo - UBS Operator Ladies and gentlemen, thank you for standi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdiction ...

MEDNAX, Inc. (NYSE:MD) Q1 2020 Earnings Conference Call May 7, 2020 10:00 AM ET Company Participants Charles Lynch - IR Roger Medel - CEO Stephen Farber - CFO Conference Call Participants Ralph Giacobbe - Citi A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Gary Taylor - JP Morgan Matthew Borsch - BMO Capital Markets Ryan Daniels - William Blair Kevin Fischbeck - Bank of America Jason Plagman - Jefferies Whit Mayo - UBS Operator Ladies and gentlemen, thank you for standing by. Welcome to the MEDNA ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or oth ...